Implantable Pacemakers, Leads & Accessories Israel - Hebräisch - Ministry of Health

implantable pacemakers, leads & accessories

גאמידה בע"מ - רופא - הפרעות קצב לב

icds,pacemakers,leads,ep sys.+accesorrie b Israel - Hebräisch - Ministry of Health

icds,pacemakers,leads,ep sys.+accesorrie b

medtronic - מומחה - לידים,ציוד לאלקטרופיזיולוגיה,דפיבריליטורים,קוצבי לב.

טירס נטורל II Israel - Hebräisch - Ministry of Health

טירס נטורל ii

lapidot medical import and marketing ltd - dextran 70; hypromellose - טיפות עיניים - hypromellose 3 mg/ml; dextran 70 1 mg/ml - hypromellose - hypromellose - dry eye syndromes. deficient tear secretion.

viscoelastic & marking materials Israel - Hebräisch - Ministry of Health

viscoelastic & marking materials

"מדי פישר הנדסה ומדע (2002) בע""מ" - רופא - חומרים ויסקואלסטיים+נוזלי סימון

viscoelastic & marking materials Israel - Hebräisch - Ministry of Health

viscoelastic & marking materials

"מדי פישר הנדסה ומדע (2002) בע""מ" - רופא - חומרים ויסקואלסטיים+נוזלי סימון

Endoscopic marking Israel - Hebräisch - Ministry of Health

endoscopic marking

מדטכניקה בע"מ - רופא - סימון אנדוסקופי

לוטמקס תרחיף Israel - Hebräisch - Ministry of Health

לוטמקס תרחיף

abic marketing ltd, israel - loteprednol etabonate - תרחיף לעין - loteprednol etabonate 5 mg / 1 ml - loteprednol - loteprednol - lotemax is indicated for the treatment of steroid responsive inflammatory conditions of the palpebral and bulbar conjunctiva, cornea and anterior segment of the globe such as allergic conjunctivitis, acne rosacea, superficial punctate keratitis, herpes zoster keratitis, iritis, cyclitis, selected infective conjunctivitides, when the inherent hazard of steroid use is accepted to otain an advisable diminution in edema and inflammation. lotemax is less effective than prednisolone acetate 1 % in two 28 day controlled clinical studies in acute anterior uveitis, where 72 % of patients treated with lotemax experienced resolution of anterior chamber cells, compared to 87 % of patients treated with prednisolone acetate 1 % . the incidence of patients with clinically significant increases in iop (> or = 10 mmhg) was 1 % with lotemax adn 6 % with prednisolone acetate 1 %. lotemax should not be used in patients who require a more potent corticosteroid for this indication. lotemax is also indicated for the treatment of po

איסדרם וטרינרי Israel - Hebräisch - Ministry of Health

איסדרם וטרינרי

vetmarket ltd, israel - betamethasone as valerate; fusidic acid as hemihydrate - ג'ל - betamethasone as valerate 0.1 %; fusidic acid as hemihydrate 0.5 %

איסוטיק וטרינרי Israel - Hebräisch - Ministry of Health

איסוטיק וטרינרי

vetmarket ltd, israel - gentamicin as sulfate; hydrocortisone aceponate; miconazole as nitrate - miconazole as nitrate 15.1 mg/ml; gentamicin as sulfate 1505 iu/ml; hydrocortisone aceponate 1.11 mg/ml